RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
HPV, diagnostic DNA chips
Diagnostics More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Clinical Trial Endpoints in Oncology - Inclusion of Surrogate Endpoints and Shorter Endpoints Will Ensure Faster Clinical Trials in Oncology
Mar 2011 - 120 pages - $3,500
SomaLogic, Inc. - Product Pipeline Analysis
Mar 2011 - 23 pages - $750
Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market
May 2011 - 7 pages - $500
Endothelin A Receptor Antagonist (atrasentan) Fails to Demonstrate an Advantage in the Treatment of Advanced Prostate Cancer
May 2011 - 5 pages - $500
Miraculins Inc. (MOM) - Product Pipeline Analysis
Mar 2011 - 20 pages - $750
Miraculins Inc. (MOM) - Product Pipeline Analysis
Nov 2010 - 26 pages - $750
Mitomics Inc. - Product Pipeline Analysis
Mar 2011 - 22 pages - $750
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
Advancing Molecular Diagnostics to Personalize Cancer Therapy
Jun 2011 - 187 pages - $3,835
Innovations in Oncology Diagnostics
Oct 2009 - 141 pages - $3,835
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Diagnostic test systems del
Therapeutic target
Oncology del
Womb cancer del
Development phase
Phase III/IV del

Browse By

Therapeutic target
Endometrial cancer
Papillary serous carcinoma
Uterine cancer

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us